Verification evidence is still being completed.
PDF / print export
LEO Pharma
Ballerup, Denmark
- Verified lead
- Christophe Bourdon
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Dermatology Therapeutics and Global Specialty Pharma Operations
- Review cycle
- May 2026
- Full address
- Industriparken 55, DK-2750 Ballerup, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official LEO Pharma leadership page confirming Christophe Bourdon as CEO.
- Editorial note
- LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node.
Dermatology Therapeutics and Global Specialty Pharma Operations
Global quality and pharmacovigilance oversight, Commercial dermatology operations
LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated05 Jun 2026, 01:06
Company profile · Ballerup, Denmark
LEO Pharma
Dermatology Therapeutics and Global Specialty Pharma Operations · Global specialty-pharma operations
Verified 15 Mar 2026 · 3 sources
Commercial
LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node.
Contact & location
- Website
- leo-pharma.com
- Company page
- Lead
- Christophe Bourdon (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Global specialty-pharma operations
- Capabilities
- Dermatology Portfolio Management · Medical Dermatology Operations · Global Quality and Regulatory Execution
- Founded
- 1908
- Headcount
- 5001-10000
Clinical profileSTATUS: VERIFIED MARCH 2026
Christophe Bourdon
Chief Executive Officer
Full addressIndustriparken 55, DK-2750 Ballerup, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Global specialty-pharma operations
Ballerup, Denmark. Dermatology Therapeutics and Global Specialty Pharma Operations. Review completed on 15 Mar 2026.
Danish Medicines Agency and global pharmaceutical oversight
Global quality and pharmacovigilance oversight, Commercial dermatology operations
Dermatology Therapeutics and Global Specialty Pharma Operations
LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node.
Editorial note
LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Dermatology Portfolio Management
Medical Dermatology Operations
Global Quality and Regulatory Execution
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Medical and regulatory operations platforms
Commercial planning infrastructure
Global portfolio governance systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is LEO Pharma located?
- LEO Pharma operates from Industriparken 55, DK-2750 Ballerup, Denmark, Ballerup, Denmark.
- Who runs LEO Pharma?
- LEO Pharma is led by Christophe Bourdon, Chief Executive Officer. Verified 15 Mar 2026.
- What does LEO Pharma do?
- LEO Pharma strengthens the Danish cluster with a directly attributable executive record, public annual-report surface, and a source-backed Ballerup headquarters node. Core capabilities: Dermatology Portfolio Management, Medical Dermatology Operations, Global Quality and Regulatory Execution.
Editorial context
Related technical briefs
Briefs that name Ballerup as a covered market or city.